Difference between revisions of "Team:technion"

 
(5 intermediate revisions by the same user not shown)
Line 60: Line 60:
  
 
.main_links a {
 
.main_links a {
font-size: 0.75em;
+
font-size: 0.7em;
 
padding-right: 15px;
 
padding-right: 15px;
 
padding-left: 15px;
 
padding-left: 15px;
Line 321: Line 321:
 
 
 
p = $("#Judging_Criteria").offset();
 
p = $("#Judging_Criteria").offset();
$("#Judging_Criteria_Links").css({"padding-left": (p.left-0)});
+
if (($(window).width())*1.5 >= screen.width)
 +
{
 +
$("#Judging_Criteria_Links").css({"padding-left": (p.left-0)});
 +
}
 +
else
 +
{
 +
p = $("#project").offset();
 +
$("#Judging_Criteria_Links").css({"padding-left": (p.left-0)});
 +
}
 
 
 
p = $("#Team").offset();
 
p = $("#Team").offset();
$("#Team_Links").css({"padding-left": (p.left-0)});
+
if (($(window).width())*1 >= screen.width)
 +
{
 +
$("#Team_Links").css({"padding-left": (p.left-0)});
 +
}
 +
else
 +
{
 +
p = $("#project").offset();
 +
$("#Team_Links").css({"padding-left": (p.left-0)});
 +
}
 
/************************reset parameters-end*****************************/
 
/************************reset parameters-end*****************************/
 
 
Line 339: Line 355:
 
 
 
p = $("#Judging_Criteria").offset();
 
p = $("#Judging_Criteria").offset();
$("#Judging_Criteria_Links").css({"padding-left": (p.left-0)});
+
if (($(window).width())*1.3 >= screen.width)
 +
{
 +
$("#Judging_Criteria_Links").css({"padding-left": (p.left-0)});
 +
}
 +
else
 +
{
 +
p = $("#project").offset();
 +
$("#Judging_Criteria_Links").css({"padding-left": (p.left-0)});
 +
}
 
 
 
p = $("#Team").offset();
 
p = $("#Team").offset();
$("#Team_Links").css({"padding-left": (p.left-0)});
+
if (($(window).width())*1 >= screen.width)
 +
{
 +
$("#Team_Links").css({"padding-left": (p.left-0)});
 +
}
 +
else
 +
{
 +
p = $("#project").offset();
 +
$("#Team_Links").css({"padding-left": (p.left-0)});
 +
}
 
});
 
});
 
/************************reset parameters on resize-end*******************/
 
/************************reset parameters on resize-end*******************/
 
 
 
/************************on hover events for main buttons*****************/
 
/************************on hover events for main buttons*****************/
$("#project, #project_Links").hover(function() {
+
$("#project, #project_Links a").hover(function() {
 
$("#project_Links").css({"max-height": "50px"});
 
$("#project_Links").css({"max-height": "50px"});
 
},
 
},
Line 354: Line 386:
 
});
 
});
 
 
$("#Lab_Notebook, #Lab_Notebook_Links").hover(function() {
+
$("#Lab_Notebook, #Lab_Notebook_Links a").hover(function() {
 
$("#Lab_Notebook_Links").css({"max-height": "50px"});
 
$("#Lab_Notebook_Links").css({"max-height": "50px"});
 
},
 
},
Line 361: Line 393:
 
});
 
});
 
 
$("#Human_Practices, #Human_Practices_Links").hover(function() {
+
$("#Human_Practices, #Human_Practices_Links a").hover(function() {
 
$("#Human_Practices_Links").css({"max-height": "50px"});
 
$("#Human_Practices_Links").css({"max-height": "50px"});
 
},
 
},
Line 368: Line 400:
 
});
 
});
 
 
$("#Judging_Criteria, #Judging_Criteria_Links").hover(function() {
+
$("#Judging_Criteria, #Judging_Criteria_Links a").hover(function() {
 
$("#Judging_Criteria_Links").css({"max-height": "50px"});
 
$("#Judging_Criteria_Links").css({"max-height": "50px"});
 
},
 
},
Line 375: Line 407:
 
});
 
});
 
 
$("#Team, #Team_Links").hover(function() {
+
$("#Team, #Team_Links a").hover(function() {
 
$("#Team_Links").css({"max-height": "50px"});
 
$("#Team_Links").css({"max-height": "50px"});
 
},
 
},

Latest revision as of 19:04, 10 September 2015

Team: Technion 2015

page title

Our team is developing a treatment for male pattern baldness.

Hair loss affects roughly 61 million people in the United States. More than 95% of hair thinning in men is attributed to male pattern baldness, or androgenetic alopecia. The hair loss product market is a multi-billion dollar market: in the United States alone, this market’s annual revenue is 7 billion dollars, with 3.5% annual growth rate from 2007 to 2012, yet a sufficient solution has yet to be made available. The trigger for androgenetic alopecia is believed to be dihydrotestosterone (DHT), a derivative of testosterone. This summer, we are engineering Bacillus Subtilis, a model organism for a bacterium found naturally on the scalp, to secrete 3α-hydroxysteroid dehydrogenase (3-α-HSD). This enzyme reduces DHT to a non-steroidically active compound, using NADPH and NADH as cofactors.

Our project consists of 3 main parts: 3-α-HSD secretion by the bacterium, engineered bacterium for NADPH overproduction, and a comb as a tool to create a user-friendly experience. By synchronizing these parts, we hope to be able to show convincing evidence of DHT breakdown, providing a promising platform for treatment of male pattern baldness!

Contact Us